Han weidong: Clinical Trials

5 trials sponsored by Han weidong, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 1 active not recruiting, 1 recruiting. 4 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Unknown 2, Active not recruiting 1, Recruiting 1
Phase 24Unknown 2, Active not recruiting 1, Recruiting 1

Follow Han weidong: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Decitabine-primed Tandem CD19/CD20 CAR T Cells Treatment in r/r B-NHL
Decitabine-primed Tandem CAR19/20 engineered T cells, Fludarabine, Cyclophosphamide - Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma, Decitabine-primed Tandem CD19/CD20 CAR T Cells
Phase 1 / Phase 2Active not recruitingHan weidong332021-04-152025-09-19
Clinical Efficacy of MOAP Regimen for Relapsed/Refractory cHL as a Rescue Therapy After DP Regimen
MOAP - Hodgkin Lymphoma
Phase 1 / Phase 2UnknownHan weidong302019-07-302019-07-19
Anti-PD-1 Antibody Alone or in Combination With Decitabine/Chemotherapy in Relapsed or Refractory Malignancies
Anti-PD-1 antibody, Decitabine, Chemotherapy - Malignancies Multiple
Phase 1 / Phase 2RecruitingHan weidong2502016-05-012026-01-22
Treatment of CD20 Antibody Plus CIK for Patients With Refractory Lymphomas
Lymphomas
UnknownHan weidong202013-04-012013-04-10
Lower Dose Decitabine Based Therapy in Patients With Refractory and/or Chemotherapy Resistant Solid Tumors or B Cell Lymphomas
Decitabine, cytokine-induced killer cell - Solid Tumors, B Cell Lymphoma
Phase 1 / Phase 2UnknownHan weidong1002012-12-012016-01-28

Conditions studied

Recurrence (3)  ·  Lymphoma, B-Cell (2)  ·  Hodgkin Disease (1)  ·  Lymphoma (1)  ·  Neoplasms (1)

Interventions

Decitabine (2)  ·  Cyclophosphamide (1)  ·  Drug Therapy (1)  ·  Injections (1)  ·  fludarabine (1)  ·  fludarabine phosphate (1)  ·  spartalizumab (1)

Countries

China (4)

Top investigators

Chunmeng Wang, Master (1)  ·  Hejin Jia, Doctor (1)  ·  Jing Nie, Doctor (1)  ·  Jingdan Qiu, Doctor (1)  ·  Kaichao Feng, Doctor (1)  ·  Liang Dong, Master (1)  ·  Lu Shi, Master (1)  ·  Meixia Chen, Doctor (1)  ·  Qian Mei, Doctor (1)  ·  Weidong Han, M.D. (1)  ·  Wenying Zhang, Master (1)  ·  Xiang Li, Master (1)  ·  Yan Zhang, Doctor (1)  ·  Yang Liu, Doctor (1)

Results publications

PMID 24382970, PMID 24963497, PMID 25895027, PMID 27191266, PMID 31039052, PMID 33674274, PMID 33820822